Instuitional Investor - Flagship Ventures Management, Inc.
Fund Profile
Filing Period:
| Fund Name: | Flagship Ventures Management, Inc. |
| Portfolio Value | $522,113,000 |
Top 13F Holdings
Filing Period:
| No. | Security | Ticker | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|---|
| 1. | Evelo Biosciences Inc | 18,233,403 | $215,154 | 41.2% | |
| 2. | Denali Therapeutics Inc | 8,918,749 | $136,011 | 26.05% | |
| 3. | Seres Therapeutics Inc | 12,682,876 | $109,073 | 20.89% | |
| 4. | Syros Pharmaceuticals Inc | 3,204,437 | $32,717 | 6.26% | |
| 5. | Quanterix Corp | 2,030,495 | $29,158 | 5.58% |
